With our growing antibiotic portfolio ... USP is available as 1.5 g and 3 g single-dose vials, and 15 g Pharmacy Bulk Package Bottles. Please see link for Full Prescribing Information.

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

Probiotics aren't as well-researched as creatine or whey protein, but they're growing in popularity—not as muscle-building ...

Vitamin A has been shown to reduce the risk of measles mortality in certain cases, but doctors said the MMR vaccine is the ...

The Environment Protection Authority says it has detected low levels of an antibiotic in the material, which it says gives rise to "further questions" about the antibiotic's presence in the ...

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic ...

The 2005 finding of cells and blood vessels in dinosaur bone launched a systematic search for fossil remnants of biomolecules, creating innovations in methods and applications. Immune cells called ...

Viral infections, such as herpes, are managed with antivirals. The best treatment—antibiotic, viral, or parasitic—depends on the type of infection. It's important to seek a diagnosis from a healthcare ...

Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with a left ventricular ejection fraction (LVEF) of ≥40%.